Viewing Study NCT03267732


Ignite Creation Date: 2025-12-24 @ 9:59 PM
Ignite Modification Date: 2025-12-25 @ 7:36 PM
Study NCT ID: NCT03267732
Status: COMPLETED
Last Update Posted: 2019-04-05
First Post: 2017-08-24
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study to Evaluate the Pharmacokinetics in Participants After Dosing With Pegilodecakin (LY3500518)
Sponsor: Eli Lilly and Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module